Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ONDO INSURTECH PLC Director's Dealing 2025

Jun 19, 2025

5074_dirs_2025-06-19_5b90628f-5084-4719-8964-1f6412ab220b.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6422N

Ondo InsurTech PLC

19 June 2025

19 June 2025

Ondo InsurTech Plc

("Ondo" or the "Company")

Director/PDMR Dealing

Ondo InsurTech Plc (LSE: ONDO), a leading company in claims prevention technology for home insurers, announces that it was notified today that, to effect a "Bed and ISA" transaction, Andy Morrison, a Non Executive Director, has today sold 200,000 Ordinary Shares a price of 21.475p per share before subsequently acquiring 200,000 Ordinary Shares at 21.5p through his ISA. 

Following this transaction Mr. Morrison's interest is unchanged at 3,400,000 ordinary shares, representing approximately 2.5 per cent of Ondo's issued ordinary share capital.

Enquiries

Ondo InsurTech Plc Craig Foster, CEO

Kevin Withington, CFO
+44 (0) 800 783 9866
Dowgate Capital Ltd

(Broker & Financial Advisor)
Russell Cook

Nick Chambers

Charlie Hall
+44 (0) 20 3903 7715
Cassiopeia Services Ltd

(PR & Investor Relations)
Stefania Barbaglio +44 (0) 7949 690338

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.

1

Details of the person discharging managerial responsibilities / person closely associated.

a)

Name

Andrew Morrison

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence each

ISIN: GB00BNVVGD77

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Prices Volumes
21.475p 200,000

d)

Aggregated information

N/A - Single transaction

e)

Date of the transaction

19 June 2025

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1

Details of the person discharging managerial responsibilities / person closely associated.

a)

Name

Andrew Morrison

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each

ISIN: GB00BNVVGD77

b)

Nature of the transaction

Purchase of Ordinary Shares via ISA

c)

Price(s) and volume(s)

Prices Volumes
21.5p 200,000

d)

Aggregated information

N/A - Single transaction

e)

Date of the transaction

19 June 2025

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFESRTIALIE